Gilead profit beats Street expectations on COVID and HIV sales
Go back to Gilead profit beats Street expectations on COVID and HIV sales| Gilead Sciences (NASDAQ: GILD) | Delayed: 125.16 +0.11 (0.09%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $125.05 | 52 Week High | $108.63 | |||
| Open | $125.56 | 52 Week Low | $71.39 | |||
| Day High | $127.27 | P/E | 69.15 | |||
| Day Low | $124.78 | EPS | $1.81 | |||
| Volume | 7,408,933 | |||||
